About this Event Previously, Boards were composed primarily of C-Suite executives who represented the shareholders.…
marknorm22nd November 2021
News & Events
About this Event Think of a biotech, or any innovative organization, as a building with…
marknorm31st August 2021
The challenges of a first-time CEO. About this Event Piers Whitehead is the first-time CEO…
marknorm22nd June 2021
“Our greatest asset is our people.” How often have we heard that corporate cliché? As…
marknorm18th May 2021
Leaders, more than ever before, need to learn to dissect conflict to try and help…
marknorm25th March 2021
Why do organisations need professionals with learning agility? The world in 2021 looks different from…
marknorm22nd February 2021
Recruiters and hiring managers are becoming exhausted from endless virtual meetings, and science has now…
marknorm5th February 2021
Diversity and inclusion - Go beyond the transactional way of responding to people and become…
marknorm28th January 2021
Despite good intentions, much of the focus of corporate D&I programs miss the mark. In…
marknorm1st December 2020
News
PharmaTimes
- Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression 17th July 2025First patient dosed in BUOY-1 study targeting MDD with or without anxious distress
- One Biosciences raises €15 million to advance single-cell oncology platform 17th July 2025Funding to accelerate development of AI-driven tumour profiling tool OneMap
- North East NHS launches digital platform to tackle chronic kidney disease 16th July 2025Healthinote rollout aims to improve early detection and patient self-management
- Proximie and HistoSonics partner to transform liver tumour treatment in US 16th July 2025Digital operating rooms and histotripsy therapy combine to improve outcomes
- NHS England secures access to new cystic fibrosis treatment ALYFTREK 15th July 2025Vertex’s once-daily triple therapy approved for eligible patients aged six and over